These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9822439)

  • 21. Angiotensin-converting enzyme gene polymorphism influences degree of left ventricular hypertrophy and its regression in patients undergoing operation for aortic stenosis.
    Dellgren G; Eriksson MJ; Blange I; Brodin LA; Rådegran K; Sylvén C
    Am J Cardiol; 1999 Oct; 84(8):909-13. PubMed ID: 10532509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic polymorphisms in the renin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene.
    Ortlepp JR; Vosberg HP; Reith S; Ohme F; Mahon NG; Schröder D; Klues HG; Hanrath P; McKenna WJ
    Heart; 2002 Mar; 87(3):270-5. PubMed ID: 11847170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial.
    Kurland L; Melhus H; Karlsson J; Kahan T; Malmqvist K; Ohman P; Nyström F; Hägg A; Lind L
    J Hypertens; 2002 Apr; 20(4):657-63. PubMed ID: 11910301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin-converting enzyme gene polymorphism, left ventricular remodeling, and exercise capacity in strength-trained athletes.
    Kasikcioglu E; Kayserilioglu A; Ciloglu F; Akhan H; Oflaz H; Yildiz S; Peker I
    Heart Vessels; 2004 Nov; 19(6):287-93. PubMed ID: 15799176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Influence of insertion-deletion polymorphism of the angiotensin converting enzyme gene on left ventricular hypertrophy in patients with aortic stenosis--differences in men and women].
    Orłowska-Baranowska E; Placha G; Gaciong Z; Zakrzewski D; Baranowski R; Kuśmierczyk-Droszcz B; Hoffman P; Rawczyńska-Englert I
    Pol Arch Med Wewn; 2002 Sep; 108(3):855-66. PubMed ID: 12600182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
    He H; Li LM; Cao WH; Sun NL; Liu MZ; Hu YH
    Ann Hum Biol; 2005; 32(1):30-43. PubMed ID: 15788353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal function dependent association of AGTR1 polymorphism (A1166C) and electrocardiographic left-ventricular hypertrophy.
    Smilde TD; Zuurman MW; Hillege HL; van Veldhuisen DJ; van Gilst WH; van der Steege G; Voors AA; Kors JA; de Jong PE; Navis G
    Am J Hypertens; 2007 Oct; 20(10):1097-103. PubMed ID: 17903694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
    Jastrzebska M; Widecka K; Ciechanowicz A; Goracy I; Wesołowska T; Torbus-Lisiecka B; Foltyńska-Nowakowska A; Naruszewicz M
    Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial hypertrophic cardiomyopathy. Insertion-deletion polymorphism of angiotensin-converting enzyme and angiotensin II receptor.
    Gilanowska G; Domal-Kwiatkowska D; Smolik S; Wilczewski P; Szarek J; Nowalany-Kozielska E; Mazurek U; Wodniecki J; Wilczok T
    Kardiol Pol; 2005 May; 62(5):440-9; 449-50. PubMed ID: 15928721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ACE I/D polymorphism and cardiac adaptations in adolescent athletes.
    Rizzo M; Gensini F; Fatini C; Manetti P; Pucci N; Capalbo A; Vono MC; Galanti G
    Med Sci Sports Exerc; 2003 Dec; 35(12):1986-90. PubMed ID: 14652492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin AT1 receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis.
    Weinberg EO; Lee MA; Weigner M; Lindpaintner K; Bishop SP; Benedict CR; Ho KK; Douglas PS; Chafizadeh E; Lorell BH
    Circulation; 1997 Mar; 95(6):1592-600. PubMed ID: 9118530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin-converting enzyme gene polymorphism and geometric patterns of hypertensive left ventricular hypertrophy.
    Ueno H; Takata M; Yasumoto K; Tomita S; Inoue H
    Jpn Heart J; 1999 Sep; 40(5):589-98. PubMed ID: 10888379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic variation in the renin-angiotensin system and athletic performance.
    Alvarez R; Terrados N; Ortolano R; Iglesias-Cubero G; Reguero JR; Batalla A; Cortina A; Fernández-García B; Rodríguez C; Braga S; Alvarez V; Coto E
    Eur J Appl Physiol; 2000 May; 82(1-2):117-20. PubMed ID: 10879452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insertion/deletion polymorphism of angiotensin I converting enzyme gene and left ventricular hypertrophy in patients with type 2 diabetes mellitus.
    Moleda P; Majkowska L; Kaliszczak R; Safranow K; Adler G; Goracy I
    Kardiol Pol; 2006 Sep; 64(9):959-65; discussion 966. PubMed ID: 17054027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic variation in angiotensin II type 2 receptor gene influences extent of left ventricular hypertrophy in hypertrophic cardiomyopathy independent of blood pressure.
    Carstens N; van der Merwe L; Revera M; Heradien M; Goosen A; Brink PA; Moolman-Smook JC
    J Renin Angiotensin Aldosterone Syst; 2011 Sep; 12(3):274-80. PubMed ID: 21163866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A/C1166 gene polymorphism of the angiotensin II type 1 receptor (AT1) and ambulatory blood pressure: the Ohasama Study.
    Kikuya M; Sugimoto K; Katsuya T; Suzuki M; Sato T; Funahashi J; Katoh R; Kazama I; Michimata M; Araki T; Hozawa A; Tsuji I; Ogihara T; Yanagisawa T; Imai Y; Matsubara M
    Hypertens Res; 2003 Feb; 26(2):141-5. PubMed ID: 12627873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients.
    Benetos A; Gautier S; Ricard S; Topouchian J; Asmar R; Poirier O; Larosa E; Guize L; Safar M; Soubrier F; Cambien F
    Circulation; 1996 Aug; 94(4):698-703. PubMed ID: 8772690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations of renin-angiotensin system genetic polymorphisms and clinical course after aneurysmal subarachnoid hemorrhage.
    Griessenauer CJ; Tubbs RS; Foreman PM; Chua MH; Vyas NA; Lipsky RH; Lin M; Iyer R; Haridas R; Walters BC; Chaudry S; Malieva A; Wilkins S; Harrigan MR; Fisher WS; Shoja MM
    J Neurosurg; 2017 May; 126(5):1585-1597. PubMed ID: 27285537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between functional polymorphisms of renin-angiotensin system, left ventricular mass, and geometry over 4 years in a healthy Chinese population aged 60 years and older.
    Lin TH; Chiu HC; Lee YT; Su HM; Voon WC; Liu HW; Lai WT; Sheu SH
    J Gerontol A Biol Sci Med Sci; 2007 Oct; 62(10):1157-63. PubMed ID: 17921431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of angiotensin converting enzyme and angiotensin II type 1 receptor genotypes with left ventricular function and mass in patients with angiographically normal coronary arteries.
    Hamon M; Amant C; Bauters C; Richard F; Helbecque N; McFadden E; Lablanche JM; Bertrand M; Amouyel P
    Heart; 1997 Jun; 77(6):502-5. PubMed ID: 9227291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.